Association of CYP2C19 and HSP70 genes polymorphism with aspirin-exacerbated respiratory disease in Kurdistan province.
CYP2C19 is a metabolizing enzyme and heat shock proteins (HSP) are induced in stress conditions, such as hypoxia and ischemia. Recently, polymorphism in CYP2C19 and HSP genes has been observed in aspirin-exacerbated respiratory disease (AERD). We investigated the polymorphism of these two genes in AERD cases within the Kurdistan population. Study involved 306 subjects, referred to the Be'sat hospital in Kurdistan Province, and were divided into three groups, (i) Aspirin induced asthma (AIA), (ii) aspirin tolerant asthma (ATA), and (iii) healthy subjects as control. The subjects as control and ATA\AIA groups were verified by the physician. The demographic data (age, sex, parental education, and residence) was collected for all the subjects. Spirometry was performed on subjects and blood samples were collected for serum immunoglobulin E and further molecular tests. Genotyping was done for CYP2C19 681G>A، CYP2C19 636G>A and HSPA1B1267A>G by using PCR-RFLP and for HSPA1B-179C>T by HRM. Demographic data were not significantly different between the three groups (p>0.05). Further, genotypes were also not significantly different in the genes of CYP2C19 681G>A, CYP2C19 636G>A and HSPA1B1267A>G (p>0.05). However, the heterozygote genotype in HSPA1B-179C>T in AIA group was higher than control group (p<0>G. In clinical tests, FEV-1, FVC, and asthma severity in the AIA group were higher than control and additionally IgE levels were lower in this group(p<0>T and HSPA1B1267A>G are related with AERD in the Kurdistan population.